MEST promotes lung cancer invasion and metastasis by interacting with VCP to activate NF-κB signaling.
MEST promotes lung cancer invasion and metastasis by interacting with VCP to activate NF-κB signaling.
复制标题
MEST通过与VCP相互作用激活NF-κB信号促进肺癌侵袭和转移
DOI:
10.1186/s13046-021-02107-1
复制
发表时间:
2021-09-24
期刊:
影响因子:
--
通讯作者:
He QY
中科院分区:
文献类型:
--
作者:
Wang Y;Zhang J;Li YJ;Yu NN;Liu WT;Liang JZ;Xu WW;Sun ZH;Li B;He QY
BackgroundCell invasion is a hallmark of metastatic cancer, leading to unfavorable clinical outcomes. In this study, we established two highly invasive lung cancer cell models (A549-i8 and H1299-i8) and identified mesoderm-specific transcript (MEST) as a novel invasive regulator of lung cancer. We aim to characterize its biological function and clinical significance in lung cancer metastasis.MethodsTranswell invasion assay was performed to establish high-invasive lung cancer cell model. Immunohistochemistry (IHC) was used to detect MEST expression in tumor tissues. Mass spectrometry and bioinformatic analyses were used to identify MEST-regulated proteins and binding partners. Co-immunoprecipitation assay was performed to detect the interaction of MEST and VCP. The biological functions of MEST were investigated in vitro and in vivo. Immunofluorescence staining was conducted to explore the colocalization of MEST and VCP.ResultsMEST overexpression promoted metastasis of lung cancer cells in vivo and in vitro by activating NF-κB signaling. MEST increased the interaction between VCP and IκBα, which accelerated IκBα degradation and NF-κB activation. Such acceleration was abrogated by VCP silencing, indicating that MEST is an upstream activator of the VCP/IκBα/NF-κB signaling pathway. Furthermore, high expressions of MEST and VCP were associated with poor survival of lung cancer patients.ConclusionCollectively, these results demonstrate that MEST plays an important role in driving invasion and metastasis of lung cancer by interacting with VCP to coordinate the IκBα/NF-κB pathway. Targeting the MEST/VCP/IκBα/NF-κB signaling pathway may be a promising strategy to treat lung cancer.
登录
查看更多内容
DOI:
10.1084/jem.188.6.1055
发表时间:
1998-09-21
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Cheng JD;Ryseck RP;Attar RM;Dambach D;Bravo R
通讯作者:
Bravo R
影响因子:
11.5
作者:
Li, Bin;Tsao, Sai Wah;Cheung, Annie L. M.
通讯作者:
Cheung, Annie L. M.
DOI:
10.1016/j.biopha.2020.110569
发表时间:
2020-10-01
期刊:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
影响因子:
--
作者:
Rasmi, Rajan Radha;Sakthivel, Kunnathur Murugesan;Guruvayoorappan, Chandrasekaran
通讯作者:
Guruvayoorappan, Chandrasekaran
影响因子:
56.9
作者:
BROWN, K;GERSTBERGER, S;SIEBENLIST, U
通讯作者:
SIEBENLIST, U
影响因子:
5.7
作者:
Li, Bin;Li, Yuk Yin;Cheung, Annie L. M.
通讯作者:
Cheung, Annie L. M.